AIM ImmunoTech Inc (AIM)

0.217 -0.02 (-7.03%) USD  |  NYAM  |  Jan 08, 16:00
0.2142 0.00 (0.00%) After-Hours: 20:00
More

AIM ImmunoTech SG&A Expense (Quarterly): 3.079M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Perspective Therapeutics Inc 6.975M
Protalix BioTherapeutics Inc 2.595M
Electromed Inc 9.387M
Xtant Medical Holdings Inc 19.38M
Armata Pharmaceuticals Inc 3.244M